Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator–Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models

Autor: Kanda, Shoichi 1, Nakashima, Ryutaro 1, Takahashi, Kanako 1, Tanaka, Jun 1, Ogawa, Junko 1, Ogata, Tsuneaki 1, Yachi, Makoto 2, Araki, Kazushi 1, Ohsumi, Jun 1, *
Zdroj: In Journal of Pharmacological Sciences 2009 111(2):155-166
Databáze: ScienceDirect